Comprehensive range of early stage drug discovery services to Pharma, Biotech and Academia. Our services are forward integrated with our API and formulation offerings, covering the entire drug value chain.
Clinical development services from Phase I to Phase III for various dosage form such as Oral solids, liquids, creams, ointments, and sterile injectable. Our integrated offerings accelerate the time to market and reduce costs for our customers.
Piramal offers contract manufacturing for API, HPAPI and a wide variety of dosage forms. We offer our solutions through a network of facilities located across North America, Europe and Asia.
ANTIBODY DRUG CONJUGATION
Piramal is the global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies.
Piramal’s Generic API division offers an indigenous basket of off-patent APIs for global markets.
Committed to Excellence
OPERATIONALIZING CUSTOMER CENTRICITY TO EXCEED EXPECTATIONS
Maintaining a customer-centric culture requires constant vigilance. The...
WHY QUALITY IS CRITICAL TO PATIENT CENTRICITY
High-quality manufacturing is the bedrock of the pharmaceutical industry...
ENACTING OPERATIONAL EXCELLENCE TO IMPROVE BIOPHARMA SERVICES
Operational excellence is a philosophy designed to deliver better result...
Big Pharma, Europe
Big Pharma, US
Generic Pharma, India
NEWS for you
Chemistry Today- May/June 2021, Vol 39 (3) E-Version: Building and Managing a Resilient Supply Chain
May 05, 2021
Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs
Mar 03, 2021
GBR Connect Series - Interview with Peter DeYoung, Piramal - USA Biopharmaceuticals, March 3, 2021.
Mar 03, 2021
READY TO DEVELOP A SUCCESSFUL PARTNERSHIP?
We will work together to create the right solution for you